Abstract
We studied piperacillin (PIPC) clinically to evaluate its utility and safety, and obtained the following results.
PIPC was given at a daily dose of 1-4g for 3-10 days by bolus injection or dripping infusion to 18 patients with various infections in the field of obstetrics and gynecology.
Four of 5 cases with intrauterine infection, 2 of 3 cases with focus infection of uterine cancer, 2 cases with perinatal intrauterine infection, 2 of 6 cases with adnexal infection and 2 cases with vulvar infection proved to respond effectively.
The overall efficacy rate was 66.7%.
No side effect or abnormal laboratory findings were observed except for 1 case with rash.
